https://orcid.org/0000-0002-9551-4324
Figures & data
Figure 1. Clinical pictures of rash during treatment. (a) Facial white patch at baseline, with irregular shapes and blurred margins. (b) One month after upadacitinib, the size of the white patch was reduced and repigmentation appeared on the edge. (c) Three months after upadacitinib, further reduction in the size and more repigmentation. His acne worsened at the same time. (d) Four months after upadacitinib, there was nearly 90% repigmentation of his facial white patch. (e) Cervical white patch at baseline. (f) one month after upadacitinib, the color of the white patch reduced. (g)&(h) Three and four months after upadacitinib, the rash showed complete repigmentation.
Data availability statement
Data sharing is not application to this article as no new data were created or analyzed in this study. Further details on the case can be available from the corresponding author upon reasonable request.